Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today.
Reported sales increased 2.3% year-over-year to $21.4 billion.
The company reported net earnings of $5.3 billion, or $2.20 per share, compared to a loss of $491 million, or $0.19 per share, last year. Adjusted EPS increased 12.4% to $2.71.
For the full year of 2024, the company expects reported sales to range between $88.0-88.4 billion and adjusted EPS to range between $10.57-10.72.
(This story will be updated shortly with an infographic)
The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
